-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
“Early detection can make all the difference,
and in Charlie’s case, it truly did.”
– Dr. Sue Cancer Vet
Charlie: case background
- Presenting with 2-week history of uveitis and blindness
- Work up and initial treatments started with internist
- Confirmed intermediate to large cell B-cell lymphoma
- Diagnosed via cytology of popliteal lymph nodes
- Started CHOP 8 September 2024
- Transferred to Oncology
Monthly rechecks
4 February 2025:
- Normal exam: CBC, chemistry panel and Nu.Q® Vet Cancer Test
11 March, 2025:
- Owners requested CBC, chemistry panel and T4
- Prominent popliteal LN, unable to get diagnostic sample to submit
- Nu.Q® Vet Cancer Test: 557 ng/mL – high risk
- Went in exam room to discuss with owner
- Plan:
- Thoracic radiographs: normal
- Abdominal ultrasound
Ultrasound results & next steps
-
- Normal size
- Within the tail of the spleen is a solitary, hypoechoic nodule, measuring 0.68×0.96 cm
-
- Expanded population of large lymphocytes, consistent with recurrence of large cell lymphoma
- With mild extramedullary hematopoiesis
-
- Restarted chemo the following week
Explore more case studies.
Discover how the Nu.Q® Vet Cancer Test is making a real difference in veterinary practices around the world. From early detection to informed treatment decisions, our case studies highlight real success stories.